ENVEDA

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 24 Jul 2024 filing date already counts against anyone who files later.

Record

Serial number

98665124

Mark type

Stylized text

Filed

24 Jul 2024

Published for opposition

17 Feb 2026

Attorney of record

Christina M. Licursi

Goods and services

• Class 003 — Cosmetics and cleaning preparations: House mark for a full line of cosmetic skin and hair care preparations for use in connection with the improvement in the appearance of human skin
• Class 005 — Pharmaceuticals: Pharmaceutical preparations for suppressing tumors and treatment of cancer, immunological and inflammation-related disease and disorders, fibrotic diseases and disorders, neurosensory-related diseases and disorders, and metabolic diseases and disorders; pharmaceuticals for use in the treatment of immunological and inflammation-related disease and disorders, fibrotic diseases and disorders, neurosensory-related diseases and disorders, and metabolic diseases and disorders; house mark for a full line of veterinary preparations for treatment of cancer, immunological and inflammation-related disease and disorders, fibrotic diseases and disorders, neurosensory-related diseases and disorders, and metabolic diseases and disorders for use in connection with companion and farm animals
• Class 031 — Natural agricultural products: House mark for agricultural, horticultural and forestry products, namely, seeds, bulbs, seedlings, live plant grafts, and live plant plugs; natural plants, roots and flowers; bulbs, seedlings, plant bulb divisions in the nature of live plant cuttings, live plant cuttings, live plant grafts, micropropagated plant seeds, tissue-cultured seedlings, and seeds for planting; agricultural and aquacultural crops, namely, crop seeds, and live plant cuttings and divisions; horticulture and forestry products, namely, unprocessed seeds for planting for aquacultural and forestry use
• Class 042 — Scientific and technological services: Pharmaceutical research and development services; scientific research and development of pharmaceutical preparations; pharmaceutical research services, namely, developing new uses for pharmaceutical compounds through the use of computer models, animal models, and controlled environments; contract research services, namely, providing scientific research and development of pharmaceutical preparations; technical consultancy and services in relation to technical research in the field of pharmaceuticals; consultancy in relation to scientific research in the field of pharmaceuticals; providing medical research and scientific research information in the field of medicine and pharmaceuticals; drug discovery services; none of the foregoing related to aerosol analysis and characterization of aerosol products in the medical, pharmaceutical and industrial fields

Owner

• Enveda Therapeutics, Inc., Boulder, CO, US
• Enveda Therapeutics, Inc., Boulder, CO, US

Prosecution history

• 17 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 17 Feb 2026 — PUBLISHED FOR OPPOSITION
• 11 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 23 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 23 Jan 2026 — EXAMINER'S AMENDMENT ENTERED
• 23 Jan 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
• 23 Jan 2026 — EXAMINERS AMENDMENT E-MAILED
• 23 Jan 2026 — EXAMINERS AMENDMENT -WRITTEN
• 18 Nov 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
• 18 Nov 2025 — FINAL REFUSAL E-MAILED
• 18 Nov 2025 — FINAL REFUSAL WRITTEN
• 31 Jul 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 31 Jul 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 31 Jul 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 05 May 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED